FTRE Stock Analysis: Buy, Sell, or Hold?
FTRE - Fortrea Holdings Inc. Common Stock
$18.16
-1.01 (-5.27%)
▼
5d:
-5.42%
30d:
+5.09%
90d:
+49.1%
WAIT
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Jul 29, 2026
0d
Get Alerted When FTRE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: FTRE shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: FTRE shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$33.33
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$20.70
12.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: FTRE is currently trading at $18.16, which is considered extended relative to its 30-day fair value range of $16.95 to $19.12. From a valuation perspective, the stock is trading at a premium (Forward PE: 17.1) compared to its historical average (15.3). At these levels, the market is pricing in 3.9% annual earnings growth.
Technical Outlook: Technically, FTRE is in a strong uptrend. Immediate support is located at $17.37, while resistance sits at $21.39. Short-term momentum is weak, with the stock down 5.3% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, FTRE is in a strong uptrend. Immediate support is located at $17.37, while resistance sits at $21.39. Short-term momentum is weak, with the stock down 5.3% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$16.95 -
$19.12
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
44.8%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.3%)
- NEUTRAL: Near Wall St target ($19.94)
- BULLISH: Expecting earnings turnaround to 3.9% growth with -4.5% revenue growth
Trading Range Analysis
30-Day Trading Range
$16.95 -
$19.12
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$17.37
Resistance Level
$21.39
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
17.14
Wall Street Target
$19.94
(+4.0%)
Revenue Growth (YoY)
-4.5%
Earnings Growth (YoY)
-57.4%
Profit Margin
-3.2%
Valuation Premium vs History
+3.9% premium
PE vs Historical
17.1 vs 15.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.9%
(market-implied from PE analysis)
1-Year Target
$19.92
(+4%)
2-Year Target
$20.69
(+8%)
3-Year Target
$21.50
(+12%)
3-Yr Target (if PE normalizes)
(PE: 17→15)
PE COMPRESSION
$19.20
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 34.9%)
$56.93
(+197%)
Base:
(SPY PE: 17.1, Growth: 34.9%)
$47.06
(+146%)
Bear:
(PE: 14.6, Growth: 34.9%)
$40.00
(+109%)
Share & Embed Analysis
Last updated: August 03, 2026 12:33 PM ET
Data refreshes hourly during market hours. Next update: 1:33 PM
Data refreshes hourly during market hours. Next update: 1:33 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FTRE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Jill G Mcconnell
SELL
1804 shares
2026-03-16
Jill G Mcconnell
SELL
5061 shares
2026-03-10
Robert Parks
SELL
1927 shares
2026-03-10
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 53 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$282 | 54 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$33 | 60 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$105 | 56 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$123 | 59 HOLD |
